📢 The ProPicks AI strategy to watch when Tech rally slows down. It did 2X the S&P in July!Unlock AI Insight

Pfizer, JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall

Published 2024-07-30, 07:30 a/m
© Reuters
MRK
-
JBLU
-
DGE
-
PFE
-
FFIV
-
TSLA
-
LDOS
-
BP
-
CRWD
-
BNTX
-

Investing.com -- U.S. stock futures edged higher Tuesday, in cautious trade ahead of the start of the latest Federal reserve meeting, and with the quarterly earnings season in full flow.

Here are some of the biggest premarket U.S. stock movers today

  • Merck (NYSE:MRK) stock fell 1.6% after the drugs company cut its full-year earnings forecast mainly due to one-time charges from its acquisition of eye-focused drug developer EyeBio.

  • Pfizer (NYSE:PFE) stock rose 1.9% after the drugs giant raised its annual profit forecast after reporting better-than-expected sales of its COVID vaccine and antiviral treatment.

  • CrowdStrike (NASDAQ:CRWD) stock fell 4.9% after CNBC reported that Delta Air Lines (NYSE:DAL), up 0.7%, had hired prominent attorney David Boies to seek damages following an outage this month that caused millions of computers to crash, leading to thousands of flight cancellations.

  • Tesla (NASDAQ:TSLA) stock rose 0.3% despite the National Highway Traffic Safety Administration saying the EV manufacturer has to recall over 1.8 million vehicles in the United States due to risk of software failure to detect an unlatched hood.

  • JetBlue (NASDAQ:JBLU) stock rose 3% after the low-cost carrier posted a surprise second-quarter profit and announced plans to deepen its cost cuts.

  • PayPal (NASDAQ:PYPL) stock rose 5% after the payments giant raised its forecast for full-year adjusted profit for the second time, betting on resilient consumer spending in the back-to-school and upcoming holiday shopping seasons.
  • BioNTech (NASDAQ:BNTX) stock rose 2% after the biotech’s cancer drug candidate showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial.

  • Diageo (LON:DGE) ADRs fell 7.3% after the drinks giant posted its first sales decline since the start of the pandemic, with the Latin America and Caribbean region experiencing a particularly sharp downturn.

  • BP (LON:BP) (NYSE:BP) ADRs rose 1.3% after the oil major reported a robust financial performance for the second quarter, lifting its dividend by 10% and confirming that its share buyback program will continue at a quarterly pace of $1.75 billion.

  • Leidos (NYSE:LDOS) stock rose 5.8% after the defense contractor raised its annual profit forecast, banking on strong worldwide weapons demand and increased defense spending amid growing geopolitical tensions.

  • F5 Networks (NASDAQ:FFIV) stock rose 13% after the cybersecurity and cloud services company forecasting fourth-quarter results above estimates.

  • Symbotic (NASDAQ:SYM) stock slumped 20% after the robotics vendor forecast current-quarter revenue and adjusted core profit below estimates.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.